Stock WXXWY WUXI BIOLOGICS (CAYMAN) INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. WuXi Biologics (Cayman) Inc. OTC Markets

Equities

WXXWY

US98260N1081

Delayed OTC Markets
Other stock markets
 12:44:26 29/05/2024 am IST 		5-day change 1st Jan Change
2.95 USD -6.65% Intraday chart for WuXi Biologics (Cayman) Inc. -11.54% -60.40%
27/05 China stocks rise as industrial profits grow; energy, semiconductor shares lead gains RE
17/05 Wuxi Biologics (Cayman) Maintains it is Not a Security Threat After House Bill Changes; Stocks Drop 3% MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Wuxi Biologics (Cayman) Maintains it is Not a Security Threat After House Bill Changes; Stocks Drop 3%
MT
Nomura Adjusts Wuxi Biologics' Price Target to HK$53.65 From HK$58.44, Keeps at Buy
MT
Hong Kong Stocks Rebound Over Unchanged Fed Rates; Wuxi Up 3%
MT
Nomura Adjusts Wuxi Biologics’ Price Target to HK$58.44 From HK$82.69, Keeps at Buy
MT
Nomura Adjusts Wuxi Biologics' Price Target to HK$82.69 From HK$86.68, Keeps at Buy
MT
Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$86.86 From HK$94.91, Keeps at Buy
MT
Nomura Adjusts WuXi Biologics' Price Target to HK$94.91 From HK$97.78, Keeps at Buy
MT
New energy shares drag China stocks lower, Fed rate-decision jitters weigh
RE
UBS Adjusts Wuxi Biologics’ Price Target to HK$113.12 From HK$110.67, Keeps at Buy
MT
Nomura Adjusts WuXi Biologics' Price Target to HK$97.78 From HK$95.75, Keeps at Buy
MT
UBS Adjusts Wuxi Biologics (Cayman)'s Price Target to HK$95.75 From HK$100.87, Keeps at Buy
MT
China stocks rise on higher-than-expected borrowing rate cut; foreign inflows surge
RE
UBS Adjusts Wuxi Biologics' Price Target to HK$110.67 From HK$142, Keeps at Buy
MT
Nomura Adjusts WuXi Biologics' Price Target to HK$100.87 From HK$103.28, Keeps at Buy
MT
Nomura Adjusts WuXi Biologics' Price Target to HK$103.28 From HK$149.92, Keeps at Buy
MT
China stocks fall as virus worries, Fed rate hike bets weigh; Hong Kong up
RE
WUXI BIOLOGICS CAYMAN : Nomura Adjusts WuXi Biologics' Price Target to HK$116.8 From HK$213.1, Keeps at Buy
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2269 Stock
  4. WXXWY Stock
  5. News WuXi Biologics (Cayman) Inc.
  6. Analyst Reco.